/**/

Clareus Scientific Medical Sciences (ISSN: 3064-8017)

Research Article | Volume 3 Issue 1 - 2026

Cox Proportional Hazards Model Analysis of Kidney Failure Incidence among Dialysis Patients in Tabuk City

Elfarazdag MM Hussein*, Amin MA Haleeb, Atif Ali Yassin, Manahil Sid Ahmed Mustafa and Sara Mohamed Ahmed Elsheikh
University of Tabuk, Tabuk, Saudi Arabia
*Corresponding Author: Elfarazdag MM Hussein, University of Tabuk, Tabuk, Saudi Arabia.

 January 26, 2026

Abstract

Purpose: Renal failure is a significant and prevalent problem in global healthcare, and dialysis is the primary intervention for end-stage renal disease. This work examines the relationship between dialysis modality and gender on the risk of developing kidney failure in Tabuk City. It is handled using the Cox Proportional Hazards Model (CPHM) and is a part of the survival analysis in nephrology.

Methodology: This research assessed 100 patients suffering from kidney failure who receive dialysis at the King Khalid Hospital in Tabuk City. Other variables of interest were dialysis type, peritoneal or Hemodialysis and Gender. The CPHM assessed the survival results considering the censored data. We also calculated hazard ratios and survival probability.

Results: The present study evaluated the effect of Peritoneal Dialysis in preventing the risk of kidney failure compared to hemodialysis using a hazard ratio of 0.436, p = 0.002. Furthermore, the males were the weaker Sex in this study as they had a significantly lower hazard rate of kidney failure than the females (hazard rate = 0.471; p = 0.006) by 52.9%. Overall survival curves also supported the better results for peritoneal dialysis and females.

Conclusion: The implications of the study stress dialysis type and gender regarding survival results, which are consistent with previous research and include regional factors. Therefore, the study's findings suggest individualized treatment strategies and multi-factorial research studies to consider more variables for accurate risk evaluation.

Keywords: Kidney Failure; Dialysis; Survival Analysis; Proportional Hazards Models; Saudi Arabia

References

  1. Firth D., et al. “Remembering Sir David Cox, 1924–2022”. Significance 19.2 (2022): 30-37.
  2. Salinas-Escudero, G., et al. “A survival analysis of COVID-19 in the Mexican population”. BMC public health 20.1 (2020): 1-8.
  3. Austin PC, N Thomas and DB Rubin. “Covariate-adjusted survival analyses in propensity-score matched samples: imputing potential time-to-event outcomes”. Statistical methods in medical research 29.3 (2020): 728-751.
  4. Chapfuwa P., et al. “Survival cluster analysis”. in Proceedings of the ACM Conference on Health, Inference, and Learning (2020).
  5. Al-Wahsh H., et al. “Accounting for the competing risk of death to predict kidney failure in adults with stage 4 chronic kidney disease”. JAMA network open 4.5 (2021): e219225.
  6. Albakr RB and JM Bargman. “A comparison of hemodialysis and PD in patients with cardiovascular disease”. Cardiology Clinics 39.3 (2021): 447-453.
  7. Ng CH., et al. “Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis”. International Urology and Nephrology 53 (2021): 1363-1371.
  8. Riehl-Tonn VJ., et al. “Sex and gender differences in health-related quality of life in individuals treated with incremental and conventional hemodialysis”. Clinical Kidney Journal 17.10 (2024): sfae273.
  9. Zhang K., et al. “Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images”. Nature biomedical engineering 5.6 (2021): 533-545.
  10. Zhou F and H Chen. “Cross-modal translation and alignment for survival analysis”. in Proceedings of the IEEE/CVF International Conference on Computer Vision (2023).
  11. Nikkarinen A., et al. “Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma”. Blood advances 7.18 (2023): 5304-5313.
  12. Kalbfleisch JD and DE Schaubel. “Fifty years of the cox model”. Annual Review of Statistics and Its Application 10.1 (2023): 1-23.
  13. Alareifi N. “Children, Identity and the Media: How Children as Active Audiences Make Use of their Favourite Screen Media Texts to Engage with their Saudi National Identity”. University of Leicester (2024).
  14. Bardo M., et al. “Methods for non-proportional hazards in clinical trials: A systematic review?”. Statistical Methods in Medical Research 33.6 (2024): 1069-1092.
  15. Rood AH, PJ Stafford and DH Rood. “San Andreas Fault Earthquake Hazard Model Validation Using Probabilistic Analysis of Precariously Balanced Rocks and Bayesian Updating”. Seismological Research Letters 95.3 (2024): 1776-1793.
  16. Wang G., et al. “Structured learning in time?dependent Cox models”. Statistics in Medicine (2024).
  17. Lim WH., et al. “Sex disparity in cause-specific and all-cause mortality among incident dialysis patients”. American Journal of Kidney Diseases 81.2 (2023): 156-167. e1.
  18. Auguste BL and JM Bargman. “PD prescription and adequacy in clinical practice: core curriculum 2023”. American Journal of Kidney Diseases 81.1 (2023): 100-109.
  19. Jankowska M., et al. “Why do we keep ignoring Sex in kidney disease?”. Clinical Kidney Journal 16.12 (2023):  2327-2335.
  20. Imakura A., et al. “DC-COX: Data collaboration CPHMfor privacy-preserving survival analysis on multiple parties”. Journal of Biomedical Informatics 137 (2023): 104264.
  21. Hoque M. “Prevalence of renal disease in Bangladesh”. International Journal of Research (IJR) 10.09 (2023).
  22. Candès E, L Lei and Z Ren. “Conformalized survival analysis”. Journal of the Royal Statistical Society Series B: Statistical Methodology 85.1 (2023): 24-45.
  23. Astley M., et al. “The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease”. Clinical Kidney Journal 16.12 (2023): 2396-2404.
  24. Janse RJ, M van Diepen and CL Ramspek. “Predicting kidney failure with the Kidney Failure Risk Equation: time to rethink probabilities”. American Journal of Kidney Diseases 82.4 (2023): 381-383.
  25. Piarulli P., et al. “PD discontinuation: to the root of the problem”. Journal of Nephrology 36.7 (2023): 1763-1776.
  26. Bu Z and C Li. “Enhancing the Quality of Life for PD Patients: A Study of Influencing Factors”. Alternative Therapies in Health & Medicine 30.1 (2024).
  27. McCallum W and MJ Sarnak. “Cardiorenal syndrome in the hospital”. Clinical Journal of the American Society of Nephrology 18.7 (2023): 933-945.
  28. Karkar A and M Wilkie. “PD in the modern era”. PD International 43.4 (2023): 301-314.
  29. Kassim MAK., et al. “Non-pharmacological interventions for pain management in Hemodialysis: A narrative review”. Journal of clinical medicine 12.16 (2023): 5390.
  30. Conte C., et al. “Role of sex hormones in prevalent kidney diseases”. International Journal of Molecular Sciences 24.9 (2023): 8244.
  31. Chesnaye NC., et al. “Differences in the epidemiology, management and outcomes of kidney disease in men and women”. Nature Reviews Nephrology 20.1 (2024): 7-20.
  32. Manju L and J Joseph. “Health-related quality of life among patients undergoing hemodialysis in a tertiary center in South Kerala”. Clinical Epidemiology and Global Health 26 (2024): 101547.
  33. Akemokwe F., et al. “Relationship between Kidney Dysfunction, Stroke Severity, and Outcomes in a Nigerian Tertiary Hospital: A Prospective Study”. Nigerian Journal of Clinical Practice 26.11 (2023): 1742-1749.
  34. Pardo MdC and B Cobo Rodríguez. “Comparison of methods to testing for diferential treatment effect under non-proportional hazards data”. Math Biosci Eng 20.10 (2023): 17646-17660.
  35. Cygu S., et al. “Comparing machine learning approaches to incorporate time-varying covariates in predicting cancer survival time”. Scientific Reports 13.1 (2023): 1370.

Citation

Elfarazdag MM Hussein., et al. “Cox Proportional Hazards Model Analysis of Kidney Failure Incidence among Dialysis Patients in Tabuk City". Clareus Scientific Medical Sciences 3.1 (2026): 08-20.

Copyright

© 2026 Elfarazdag MM Hussein., et al. Licensee Clareus Scientific Publications. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.